Midface Injectable Fillers : Have They Replaced Midface Surgery? - 02/06/13
Résumé |
This article examines the increasing role of injectable fillers to treat midface aging and our approach to decision making regarding the use of fillers versus surgery. We discuss the volume changes of the aging midface and advocate taking an anatomic approach to correct these changes. We discuss our approach to patient selection and injection technique. Finally, we review potential complications from injectable fillers and discuss the management of complications.
Le texte complet de cet article est disponible en PDF.Keywords : Midface lift, Midface aging, Facial analysis, Midface fillers, Tear trough fillers, Filler complications
Plan
Disclosures/Conflict of Interest: E.F. Williams, III, MD, FACS is a shareholder of Allergan stock and has previously been a principal investigator for clinical trials for Allergan and Sanofi-Aventis. A.T. Pontius, MD and S.R. Chaiet, MD: None. |
Vol 21 - N° 2
P. 229-239 - mai 2013 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?